174 related articles for article (PubMed ID: 17031405)
1. The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands.
van Vliet EP; Eijkemans MJ; Steyerberg EW; Kuipers EJ; Tilanus HW; van der Gaast A; Siersema PD
Br J Cancer; 2006 Nov; 95(9):1180-5. PubMed ID: 17031405
[TBL] [Abstract][Full Text] [Related]
2. [Non-metastatic oesophageal cancer: diagnosis and treatment].
Voeten DM; den Bakker CM; Goedegebuure RSA; Heineman DJ; Daams F; van der Peet DL
Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556490
[TBL] [Abstract][Full Text] [Related]
3. The effect of socioeconomic status on staging and treatment decisions in esophageal cancer.
Bus P; Aarts MJ; Lemmens VE; van Oijen MG; Creemers GJ; Nieuwenhuijzen GA; van Baal JW; Siersema PD
J Clin Gastroenterol; 2012; 46(10):833-9. PubMed ID: 22460163
[TBL] [Abstract][Full Text] [Related]
4. Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Nieuwenhuijzen GA
Cancer Epidemiol; 2015 Dec; 39(6):863-9. PubMed ID: 26651448
[TBL] [Abstract][Full Text] [Related]
5. Hospital of diagnosis and probability to receive a curative treatment for oesophageal cancer.
Koëter M; van Steenbergen LN; Lemmens VE; Rutten HJ; Roukema JA; Wijnhoven BP; Nieuwenhuijzen GA
Eur J Surg Oncol; 2014 Oct; 40(10):1338-45. PubMed ID: 24484779
[TBL] [Abstract][Full Text] [Related]
6. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
Trip AK; Stiekema J; Visser O; Dikken JL; Cats A; Boot H; van Sandick JW; Jansen EP; Verheij M
Acta Oncol; 2015 Nov; 54(10):1754-62. PubMed ID: 25797568
[TBL] [Abstract][Full Text] [Related]
7. Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.
Thein HH; Anyiwe K; Jembere N; Yu B; De P; Earle CC
PLoS One; 2017; 12(10):e0186350. PubMed ID: 29020052
[TBL] [Abstract][Full Text] [Related]
8. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL;
Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163
[TBL] [Abstract][Full Text] [Related]
9. The effect of socioeconomic status on health-care delay and treatment of esophageal cancer.
Wang N; Cao F; Liu F; Jia Y; Wang J; Bao C; Wang X; Song Q; Tan B; Cheng Y
J Transl Med; 2015 Jul; 13():241. PubMed ID: 26205792
[TBL] [Abstract][Full Text] [Related]
10. Healthcare resource use and medical costs for the management of oesophageal cancer.
Gordon LG; Eckermann S; Hirst NG; Watson DI; Mayne GC; Fahey P; Whiteman DC;
Br J Surg; 2011 Nov; 98(11):1589-98. PubMed ID: 22059235
[TBL] [Abstract][Full Text] [Related]
11. SEOM clinical guidelines for the treatment of oesophageal cancer.
Gallego J; Cervantes A; Pericay C; Isla D
Clin Transl Oncol; 2011 Aug; 13(8):520-4. PubMed ID: 21821484
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?
Ranney DN; Mulvihill MS; Yerokun BA; Fitch Z; Sun Z; Yang CF; D'Amico TA; Hartwig MG
Eur J Cardiothorac Surg; 2017 Sep; 52(3):543-551. PubMed ID: 28498967
[TBL] [Abstract][Full Text] [Related]
13. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and evaluation of the extent of cancer of the esophagus].
Lambert R; Jacob P
Rev Prat; 1999 Jun; 49(11):1166-71. PubMed ID: 10416346
[TBL] [Abstract][Full Text] [Related]
15. The age-related incidences of oesophageal carcinoma in intellectually disabled individuals in institutes in The Netherlands.
Böhmer CJ; Klinkenberg-Knol EC; Niezen-de Boer RC; Meuwissen SG
Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):589-92. PubMed ID: 9222731
[TBL] [Abstract][Full Text] [Related]
16. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ; Spaander MCW; Valkema R; Wijnhoven BPL; van Berge Henegouwen MI; Shapiro J; Biermann K; van der Gaast A; van Hillegersberg R; Hulshof MCCM; Krishnadath KK; Lagarde SM; Nieuwenhuijzen GAP; Oostenbrug LE; Siersema PD; Schoon EJ; Sosef MN; Steyerberg EW; van Lanschot JJB;
Lancet Oncol; 2018 Jul; 19(7):965-974. PubMed ID: 29861116
[TBL] [Abstract][Full Text] [Related]
17. Socio-economic status influences the likelihood of undergoing surgical treatment for pancreatic cancer in the Netherlands.
Bakens MJAM; Lemmens VEPP; de Hingh IHJT
HPB (Oxford); 2017 May; 19(5):443-448. PubMed ID: 28223043
[TBL] [Abstract][Full Text] [Related]
18. Potential impact of preoperative EUS on esophageal cancer management and cost.
Shumaker DA; de Garmo P; Faigel DO
Gastrointest Endosc; 2002 Sep; 56(3):391-6. PubMed ID: 12196778
[TBL] [Abstract][Full Text] [Related]
19. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area.
Islami F; Kamangar F; Nasrollahzadeh D; Aghcheli K; Sotoudeh M; Abedi-Ardekani B; Merat S; Nasseri-Moghaddam S; Semnani S; Sepehr A; Wakefield J; Møller H; Abnet CC; Dawsey SM; Boffetta P; Malekzadeh R
Int J Epidemiol; 2009 Aug; 38(4):978-88. PubMed ID: 19416955
[TBL] [Abstract][Full Text] [Related]
20. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
